Medpace Holdings Inc.

Last updated September 27, 2026

Organization details

Legal name
Medpace Holdings Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
8731 — Services-Commercial Physical & Biological Research
Jurisdiction of incorporation
Delaware
Headquarters city
Cincinnati
Headquarters state / province
Ohio
Headquarters country
United States
Fiscal year end
December
Ticker symbol
MEDP
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001668397
EIN
32-0434904

Board of directors

Chief executives

Dates unknown

Director election results

Annual meeting of May 16, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$430,050,016
54 sales by 9 insiders
Date Insider Transaction Shares Price Value
Oct 29, 2026 EWALD STEPHEN P Officer (General Counsel & Corp. Secy.) Open-market sale −1,245 $690.00 $859,050
Oct 27, 2026 BURWIG SUSAN E Officer (Exec. VP, Operations) Open-market sale −3,940 $677.00 $2,667,380
Oct 26, 2026 BURWIG SUSAN E Officer (Exec. VP, Operations) Open-market sale −16,060 $677.00 $10,872,620
Oct 26, 2026 BURWIG SUSAN E Officer (Exec. VP, Operations) Option exercise +328 $166.73 $54,687
Oct 21, 2026 BURWIG SUSAN E Officer (Exec. VP, Operations) Option exercise +2,700 $166.73 $450,171
Oct 7, 2026 BURWIG SUSAN E Officer (Exec. VP, Operations) Option exercise +2,000 $166.73 $333,460
Sep 30, 2026 Brian T. Carley Director Option exercise +36 — —
Sep 30, 2026 Robert O. Kraft Director Option exercise +32 — —
Sep 30, 2026 Cornelius P. McCarthy III Director Option exercise +28 — —
Sep 30, 2026 August J. Troendle Director, Officer (President & CEO), 10% owner Open-market sale −21,966 $625.47 $13,739,074
Sep 29, 2026 August J. Troendle Director, Officer (President & CEO), 10% owner Open-market sale −26,701 $621.02 $16,581,855
Sep 28, 2026 August J. Troendle Director, Officer (President & CEO), 10% owner Open-market sale −2,410 $620.07 $1,494,369
Sep 25, 2026 August J. Troendle Director, Officer (President & CEO), 10% owner Open-market sale −154 $620.60 $95,572
Sep 24, 2026 August J. Troendle Director, Officer (President & CEO), 10% owner Open-market sale −27,833 $621.33 $17,293,478
Sep 23, 2026 August J. Troendle Director, Officer (President & CEO), 10% owner Open-market sale −16,083 $628.64 $10,110,417

Organizations in the same sector, closest in location and size first.

Questions about Medpace Holdings Inc.

Who is the CEO of Medpace Holdings Inc.?

August J. Troendle is Medpace Holdings Inc.'s CEO.

How many directors are on Medpace Holdings Inc.'s board?

Medpace Holdings Inc.'s board has 8 directors: Ashley M. Keating, August J. Troendle, Brian T. Carley, Cornelius P. McCarthy III, Dani S. Zander, Femida H. Gwadry-Sridhar, Fred B. Davenport Jr. and Robert O. Kraft.

Are Medpace Holdings Inc. insiders buying or selling shares?

Over the last 12 months, Medpace Holdings Inc. insiders made no open-market purchases and sold $430.1 million of shares in 54 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="medpace-holdings-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.